Navigation Links
Gleevec gets hopeful results

The Food and Drug Administration approved the drug, Gleevec, for the treatment of chronic myelogenous leukemia, a form of cancer that affects about 4,500 people in the USA each year. A study supports Gleevec's image as a potential cure for this kind of cancer, which, although cases are rare, can be deadly. //

A new study adds to the evidence suggesting that a heavily publicized drug treatment for a type of leukemia may allow patients to live longer than expected. Experts say the drug, made by Novartis Pharmaceuticals also holds promise for the treatment of lung cancer, prostate cancer and a form of stomach cancer.

In the longest study of the drug so far, researchers studied 532 patients with chronic leukemia. They all had received the standard drug, interferon, but after six months their cancer had gotten worse. The patients were switched to Gleevec, which they took once a day. After 18 months, the researchers could find no visible sign of the genetic abnormality that causes the disease in 41% of the patients.

That genetic flaw leads to the production of a protein that allows white cells in the blood and in the bone marrow to run out of control. Gleevec works by blocking the action of that protein.
'"/>




Page: 1

Related medicine news :

1. Gleevec for Lung Disease
2. "Miracle" Cancer Drug Gleevec Can be Toxic to the Heart
3. Novartis Gleevec Found Effective in Treating Gastro-intestinal Tumors
4. Artificial disc looks hopeful
5. Experimental treatment for Ebola Virus Shows promising results in mice
6. IVF results may be affected by stress and other related factors
7. New dosage of medicine gets more results in neuroblastoma
8. Caffeine can interfere with PET scan results
9. Mouth wash samples to predict bone marrow transplant results
10. PET scans can detect the results of cognitive behavior therapy
11. Induced abortion results in years of trauma.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology: